Nanoparticle-based vaccine delivery for cancer immunotherapy.
Yeong-Min Park, Seung Jun Lee, Young Seob Kim, Moon Hee Lee, Gil Sun Cha, In Duk Jung, Tae Heung Kang, Hee Dong Han
Author Information
Yeong-Min Park: Department of Immunology, School of Medicine, Konkuk University, Chungju 380-701, Korea.
Development of nano-sized carriers including nanoparticles, nanoemulsions or liposomes holds great potential for advanced delivery systems for cancer immunotherapy, as such nanostructures can be used to more effectively manipulate or deliver immunologically active components to specific target sites. Successful development of nanotechnology based platform in the field of immunotherapy will allow the application of vaccines, adjuvants and immunomodulatory drugs that improve clinical outcomes for immunological diseases. Here, we review current nanoparticle-based platforms in the efficacious delivery of vaccines in cancer immunotherapy.
Eur J Pharm Biopharm. 2013 Nov;85(3 Pt A):427-43
[PMID: 23872180 ]
Prog Neurobiol. 2009 Feb;87(3):133-70
[PMID: 18926873 ]
Mol Pharm. 2008 Jul-Aug;5(4):505-15
[PMID: 18672949 ]
Curr Opin Allergy Clin Immunol. 2012 Dec;12(6):658-64
[PMID: 23095912 ]
Proc Natl Acad Sci U S A. 2012 Apr 3;109(14):E797-803
[PMID: 22421433 ]
Clin Pharmacol Ther. 2008 May;83(5):761-9
[PMID: 17957183 ]
Nanoscale Res Lett. 2007 Aug 15;2(9):430-41
[PMID: 21794189 ]
Methods. 2013 May 1;60(3):232-41
[PMID: 23643867 ]
Curr Allergy Asthma Rep. 2013 Feb;13(1):50-7
[PMID: 22941559 ]
Nanomedicine. 2011 Feb;7(1):1-10
[PMID: 20692374 ]
Small. 2012 Jul 23;8(14):2222-30
[PMID: 22528663 ]
Biomaterials. 2013 Nov;34(33):8291-300
[PMID: 23910466 ]
Biomaterials. 2013 Apr;34(12):3042-52
[PMID: 23374704 ]
Curr Opin Biotechnol. 2013 Dec;24(6):1089-93
[PMID: 23481378 ]
Int J Pharm. 2005 Jul 25;298(2):315-22
[PMID: 15961266 ]
Nanomedicine. 2010 Oct;6(5):651-61
[PMID: 20348031 ]
J Control Release. 2013 Jun 10;168(2):179-99
[PMID: 23524187 ]
Immunology. 2006 Jan;117(1):78-88
[PMID: 16423043 ]
Biomaterials. 2013 Dec;34(37):9709-16
[PMID: 24016848 ]
Immune Netw. 2011 Feb;11(1):79-94
[PMID: 21494377 ]
Adv Drug Deliv Rev. 2013 Nov;65(13-14):1816-27
[PMID: 23932923 ]
Immunity. 2003 Jul;19(1):71-82
[PMID: 12871640 ]
Nat Rev Immunol. 2013 Aug;13(8):592-605
[PMID: 23883969 ]
Nat Biotechnol. 2007 Oct;25(10):1159-64
[PMID: 17873867 ]
Adv Drug Deliv Rev. 2011 Nov;63(14-15):1228-46
[PMID: 21777633 ]
Eur J Pharm Biopharm. 2013 Nov;85(3 Pt A):550-9
[PMID: 23831265 ]
Front Cell Infect Microbiol. 2013 Mar 25;3:13
[PMID: 23532930 ]
Angew Chem Int Ed Engl. 2012 Aug 27;51(35):8800-5
[PMID: 22847719 ]
Angew Chem Int Ed Engl. 2013 Jul 22;52(30):7684-9
[PMID: 23765547 ]
Vaccine. 2009 May 18;27(23):3013-21
[PMID: 19428913 ]
Angew Chem Int Ed Engl. 2012 Sep 17;51(38):9670-3
[PMID: 22915476 ]
Mol Pharm. 2007 Jan-Feb;4(1):73-84
[PMID: 17274665 ]
Proc Natl Acad Sci U S A. 2011 Nov 1;108(44):E989-97
[PMID: 21969597 ]
ACS Nano. 2012 Sep 25;6(9):8041-51
[PMID: 22920601 ]
Nat Nanotechnol. 2011 Sep 11;6(10):675-82
[PMID: 21909083 ]
Nano Lett. 2012 Oct 10;12(10):5304-10
[PMID: 22920324 ]
Pain Physician. 2013 May-Jun;16(3):E199-216
[PMID: 23703419 ]
Nature. 2013 Jul 4;499(7456):102-6
[PMID: 23698367 ]
Nat Rev Immunol. 2010 Nov;10(11):787-96
[PMID: 20948547 ]
Expert Opin Drug Deliv. 2009 Nov;6(11):1149-60
[PMID: 19780712 ]
J Drug Deliv. 2011;2011:727241
[PMID: 21512579 ]
Int J Nanomedicine. 2013;8:1683-96
[PMID: 23761969 ]
J Control Release. 2002 Dec 13;85(1-3):247-62
[PMID: 12480329 ]
J Biomed Nanotechnol. 2013 Jun;9(6):1008-16
[PMID: 23858965 ]
Exp Mol Med. 2012 May 31;44(5):340-9
[PMID: 22322306 ]
J Control Release. 2008 Aug 25;130(1):22-8
[PMID: 18554742 ]
